Lundbeck Q3 2019 Financial Results

Migraine prevention represents a large and under served market Addressable population (major countries¹) Migraine is divided into two major categories, episodic and chronic depending on the frequency of headaches 1-14 migraine days per month >14 migraine I days per month 24 -134m - Migraine prevalence ~41m - diagnosed patients (30%) ~18m - Eligible for prevention (43%) -9m - Currently on prophylactic treatment 1) Decision Resource, DRG 2018 Migraine Market report. Covers G7+China Episodic Frequent episodic I Acute treatment <4 migraine days per month Chronic Migraine prevention >4 migraine days per month Lundbeck

View entire presentation